Suntrust Banks’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Suntrust Banks's PFE Position: Q3 2019 in Review
Suntrust Banks reduced its Pfizer (PFE) stake by 19% in Q3 2019, selling an estimated $25.6M and leaving 2,977,304 shares worth $101M. The position accounts for 0.53% of the portfolio, ranked #38.
Suntrust Banks first reported a position in PFE in Q2 2013 and has held it in 26 quarters since. The position peaked at $237M in Q1 2014. 2,323 funds tracked by Wall St. Rank hold PFE as of Q3 2019.
- Suntrust Banks held 2,977,304 shares of Pfizer worth $101M as of Q3 2019.
- Suntrust Banks sold 702,776 Pfizer shares in Q3 2019, an estimated $25.6M.
- Pfizer made up 0.53% of Suntrust Banks's portfolio in Q3 2019, its #38 holding.
- Suntrust Banks first reported a position in Pfizer in Q2 2013 and has held it in 26 quarters since.
- Suntrust Banks's Pfizer position peaked at $237M in Q1 2014.
- 2,323 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.
Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.